Related Experiment Video
Updated: Jul 18, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
RNAi expression mediated inhibition of HCV replication
Hiroyuki Hamazaki1, Saneyuki Ujino, Emi Abe
1Department of Life and Environmental Sciences, Chiba Institute of Technology, 2-17-1 Tsudanuma, Narashino, Chiba 275-0016, Japan.
Longer dsRNA effectively inhibited Hepatitis C Virus (HCV) RNA replication in cells. This RNA interference (RNAi) approach shows promise for developing siRNA gene therapy to treat Hepatitis C.
Area of Science:
- Molecular Biology
- Virology
- Gene Therapy
Background:
- RNA interference (RNAi) is a natural process where double-stranded RNA (dsRNA) triggers specific messenger RNA (mRNA) degradation.
- Short interfering RNAs (siRNAs), 21-23 nucleotides long, are key mediators generated from longer dsRNAs.
Purpose of the Study:
- To investigate the efficacy of vector-derived dsRNA in inhibiting Hepatitis C Virus (HCV) RNA replication.
- To evaluate the potential of long dsRNA targeting the HCV IRES region for therapeutic applications.
Main Methods:
- Designed a long dsRNA targeting the full-length HCV IRES region (1-377 nucleotides).
- Utilized Real-Time RT-PCR with TaqMan technology for precise quantification of HCV RNA levels.
Main Results:
- Vector-derived dsRNA significantly inhibited HCV RNA replication in a sequence-specific manner.
- HCV replication was reduced to near background levels in treated cells.
Conclusions:
- Long dsRNAs targeting the HCV IRES region demonstrate potent antiviral activity.
- These findings support the potential of siRNA gene therapy for treating Hepatitis C infection.
Related Concept Videos
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release

